Your browser doesn't support javascript.
loading
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer.
Takeda, Toshikazu; Tin, Amy L; Corradi, Renato B; Alvim, Ricardo; Hashimoto, Takeshi; Ito, Yujiro; Nguyen, Daniel P; Mamoor, Maha; Robertson, Nicola L; Vargas, Hebert A; Benfante, Nicole E; Sjoberg, Daniel D; Eastham, James A; Scardino, Peter T; Fine, Samson W; Oya, Mototsugu; Touijer, Karim A.
Afiliación
  • Takeda T; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Tin AL; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Corradi RB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Alvim R; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Hashimoto T; Mario Penna Cancer Institute, Belo Horizonte, Brazil.
  • Ito Y; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Nguyen DP; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Mamoor M; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Robertson NL; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Vargas HA; Urology Service, Hospital Neuchâtelois, Neuchâtel, Switzerland.
  • Benfante NE; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Sjoberg DD; Departments of, Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Eastham JA; Departments of, Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Scardino PT; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Fine SW; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Oya M; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Touijer KA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Int J Urol ; 27(2): 179-185, 2020 Feb.
Article en En | MEDLINE | ID: mdl-31833113
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos